English
简体中文
Total: £ 56.28
Published Date: 2024-07-12 | Pages: 97 | Tables: 189 | New Technology
Controls based on viral nucleic acids extracted from either an infected patient or from live virus propagated in cell culture have safety and security concerns.
The global Synthetic Viral Controls market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Synthetic Viral Controls is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Synthetic Viral Controls is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Synthetic Viral Controls in Child is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Synthetic Viral Controls include Twist Bioscience, Vector Biolabs, Premade Lentivirus Particles, Telesis Bio, Thermo Fisher Scientific, Sigma Aldrich, Antibody Engineering, Amyris and Precigen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Synthetic Viral Controls, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Synthetic Viral Controls.
Report Scope
The Synthetic Viral Controls market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Synthetic Viral Controls market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Synthetic Viral Controls companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Twist Bioscience
Vector Biolabs
Premade Lentivirus Particles
Telesis Bio
Thermo Fisher Scientific
Sigma Aldrich
Antibody Engineering
Amyris
Precigen
Ginkgo Bioworks
Codexis
Impossible Foods
National Resilience
ElevateBio
Insitro
Apeel Sciences
Segment by Type
Monkeypox Controls
SARS-COV-2 CONTROLS
Respiratory Virus Controls
Segment by Application
Child
Teenager
Youth
Middle-Aged
Elder
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Synthetic Viral Controls companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Synthetic Viral Controls Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monkeypox Controls
1.2.3 SARS-COV-2 CONTROLS
1.2.4 Respiratory Virus Controls
1.3 Market by Application
1.3.1 Global Synthetic Viral Controls Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Child
1.3.3 Teenager
1.3.4 Youth
1.3.5 Middle-Aged
1.3.6 Elder
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Synthetic Viral Controls Market Perspective (2019-2030)
2.2 Synthetic Viral Controls Growth Trends by Region
2.2.1 Global Synthetic Viral Controls Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Synthetic Viral Controls Historic Market Size by Region (2019-2024)
2.2.3 Synthetic Viral Controls Forecasted Market Size by Region (2025-2030)
2.3 Synthetic Viral Controls Market Dynamics
2.3.1 Synthetic Viral Controls Industry Trends
2.3.2 Synthetic Viral Controls Market Drivers
2.3.3 Synthetic Viral Controls Market Challenges
2.3.4 Synthetic Viral Controls Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Synthetic Viral Controls Players by Revenue
3.1.1 Global Top Synthetic Viral Controls Players by Revenue (2019-2024)
3.1.2 Global Synthetic Viral Controls Revenue Market Share by Players (2019-2024)
3.2 Global Synthetic Viral Controls Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Synthetic Viral Controls Revenue
3.4 Global Synthetic Viral Controls Market Concentration Ratio
3.4.1 Global Synthetic Viral Controls Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Synthetic Viral Controls Revenue in 2023
3.5 Synthetic Viral Controls Key Players Head office and Area Served
3.6 Key Players Synthetic Viral Controls Product Solution and Service
3.7 Date of Enter into Synthetic Viral Controls Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Synthetic Viral Controls Breakdown Data by Type
4.1 Global Synthetic Viral Controls Historic Market Size by Type (2019-2024)
4.2 Global Synthetic Viral Controls Forecasted Market Size by Type (2025-2030)
5 Synthetic Viral Controls Breakdown Data by Application
5.1 Global Synthetic Viral Controls Historic Market Size by Application (2019-2024)
5.2 Global Synthetic Viral Controls Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Synthetic Viral Controls Market Size (2019-2030)
6.2 North America Synthetic Viral Controls Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Synthetic Viral Controls Market Size by Country (2019-2024)
6.4 North America Synthetic Viral Controls Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Synthetic Viral Controls Market Size (2019-2030)
7.2 Europe Synthetic Viral Controls Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Synthetic Viral Controls Market Size by Country (2019-2024)
7.4 Europe Synthetic Viral Controls Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Synthetic Viral Controls Market Size (2019-2030)
8.2 Asia-Pacific Synthetic Viral Controls Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Synthetic Viral Controls Market Size by Region (2019-2024)
8.4 Asia-Pacific Synthetic Viral Controls Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Synthetic Viral Controls Market Size (2019-2030)
9.2 Latin America Synthetic Viral Controls Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Synthetic Viral Controls Market Size by Country (2019-2024)
9.4 Latin America Synthetic Viral Controls Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Synthetic Viral Controls Market Size (2019-2030)
10.2 Middle East & Africa Synthetic Viral Controls Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Synthetic Viral Controls Market Size by Country (2019-2024)
10.4 Middle East & Africa Synthetic Viral Controls Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Twist Bioscience
11.1.1 Twist Bioscience Company Detail
11.1.2 Twist Bioscience Business Overview
11.1.3 Twist Bioscience Synthetic Viral Controls Introduction
11.1.4 Twist Bioscience Revenue in Synthetic Viral Controls Business (2019-2024)
11.1.5 Twist Bioscience Recent Development
11.2 Vector Biolabs
11.2.1 Vector Biolabs Company Detail
11.2.2 Vector Biolabs Business Overview
11.2.3 Vector Biolabs Synthetic Viral Controls Introduction
11.2.4 Vector Biolabs Revenue in Synthetic Viral Controls Business (2019-2024)
11.2.5 Vector Biolabs Recent Development
11.3 Premade Lentivirus Particles
11.3.1 Premade Lentivirus Particles Company Detail
11.3.2 Premade Lentivirus Particles Business Overview
11.3.3 Premade Lentivirus Particles Synthetic Viral Controls Introduction
11.3.4 Premade Lentivirus Particles Revenue in Synthetic Viral Controls Business (2019-2024)
11.3.5 Premade Lentivirus Particles Recent Development
11.4 Telesis Bio
11.4.1 Telesis Bio Company Detail
11.4.2 Telesis Bio Business Overview
11.4.3 Telesis Bio Synthetic Viral Controls Introduction
11.4.4 Telesis Bio Revenue in Synthetic Viral Controls Business (2019-2024)
11.4.5 Telesis Bio Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Synthetic Viral Controls Introduction
11.5.4 Thermo Fisher Scientific Revenue in Synthetic Viral Controls Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Sigma Aldrich
11.6.1 Sigma Aldrich Company Detail
11.6.2 Sigma Aldrich Business Overview
11.6.3 Sigma Aldrich Synthetic Viral Controls Introduction
11.6.4 Sigma Aldrich Revenue in Synthetic Viral Controls Business (2019-2024)
11.6.5 Sigma Aldrich Recent Development
11.7 Antibody Engineering
11.7.1 Antibody Engineering Company Detail
11.7.2 Antibody Engineering Business Overview
11.7.3 Antibody Engineering Synthetic Viral Controls Introduction
11.7.4 Antibody Engineering Revenue in Synthetic Viral Controls Business (2019-2024)
11.7.5 Antibody Engineering Recent Development
11.8 Amyris
11.8.1 Amyris Company Detail
11.8.2 Amyris Business Overview
11.8.3 Amyris Synthetic Viral Controls Introduction
11.8.4 Amyris Revenue in Synthetic Viral Controls Business (2019-2024)
11.8.5 Amyris Recent Development
11.9 Precigen
11.9.1 Precigen Company Detail
11.9.2 Precigen Business Overview
11.9.3 Precigen Synthetic Viral Controls Introduction
11.9.4 Precigen Revenue in Synthetic Viral Controls Business (2019-2024)
11.9.5 Precigen Recent Development
11.10 Ginkgo Bioworks
11.10.1 Ginkgo Bioworks Company Detail
11.10.2 Ginkgo Bioworks Business Overview
11.10.3 Ginkgo Bioworks Synthetic Viral Controls Introduction
11.10.4 Ginkgo Bioworks Revenue in Synthetic Viral Controls Business (2019-2024)
11.10.5 Ginkgo Bioworks Recent Development
11.11 Codexis
11.11.1 Codexis Company Detail
11.11.2 Codexis Business Overview
11.11.3 Codexis Synthetic Viral Controls Introduction
11.11.4 Codexis Revenue in Synthetic Viral Controls Business (2019-2024)
11.11.5 Codexis Recent Development
11.12 Impossible Foods
11.12.1 Impossible Foods Company Detail
11.12.2 Impossible Foods Business Overview
11.12.3 Impossible Foods Synthetic Viral Controls Introduction
11.12.4 Impossible Foods Revenue in Synthetic Viral Controls Business (2019-2024)
11.12.5 Impossible Foods Recent Development
11.13 National Resilience
11.13.1 National Resilience Company Detail
11.13.2 National Resilience Business Overview
11.13.3 National Resilience Synthetic Viral Controls Introduction
11.13.4 National Resilience Revenue in Synthetic Viral Controls Business (2019-2024)
11.13.5 National Resilience Recent Development
11.14 ElevateBio
11.14.1 ElevateBio Company Detail
11.14.2 ElevateBio Business Overview
11.14.3 ElevateBio Synthetic Viral Controls Introduction
11.14.4 ElevateBio Revenue in Synthetic Viral Controls Business (2019-2024)
11.14.5 ElevateBio Recent Development
11.15 Insitro
11.15.1 Insitro Company Detail
11.15.2 Insitro Business Overview
11.15.3 Insitro Synthetic Viral Controls Introduction
11.15.4 Insitro Revenue in Synthetic Viral Controls Business (2019-2024)
11.15.5 Insitro Recent Development
11.16 Apeel Sciences
11.16.1 Apeel Sciences Company Detail
11.16.2 Apeel Sciences Business Overview
11.16.3 Apeel Sciences Synthetic Viral Controls Introduction
11.16.4 Apeel Sciences Revenue in Synthetic Viral Controls Business (2019-2024)
11.16.5 Apeel Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Synthetic Viral Controls Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Monkeypox Controls
Table 3. Key Players of SARS-COV-2 CONTROLS
Table 4. Key Players of Respiratory Virus Controls
Table 5. Global Synthetic Viral Controls Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Synthetic Viral Controls Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Synthetic Viral Controls Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Synthetic Viral Controls Market Share by Region (2019-2024)
Table 9. Global Synthetic Viral Controls Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Synthetic Viral Controls Market Share by Region (2025-2030)
Table 11. Synthetic Viral Controls Market Trends
Table 12. Synthetic Viral Controls Market Drivers
Table 13. Synthetic Viral Controls Market Challenges
Table 14. Synthetic Viral Controls Market Restraints
Table 15. Global Synthetic Viral Controls Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Synthetic Viral Controls Market Share by Players (2019-2024)
Table 17. Global Top Synthetic Viral Controls Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Viral Controls as of 2023)
Table 18. Ranking of Global Top Synthetic Viral Controls Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Synthetic Viral Controls Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Synthetic Viral Controls Product Solution and Service
Table 22. Date of Enter into Synthetic Viral Controls Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Synthetic Viral Controls Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Synthetic Viral Controls Revenue Market Share by Type (2019-2024)
Table 26. Global Synthetic Viral Controls Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Synthetic Viral Controls Revenue Market Share by Type (2025-2030)
Table 28. Global Synthetic Viral Controls Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Synthetic Viral Controls Revenue Market Share by Application (2019-2024)
Table 30. Global Synthetic Viral Controls Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Synthetic Viral Controls Revenue Market Share by Application (2025-2030)
Table 32. North America Synthetic Viral Controls Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Synthetic Viral Controls Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Synthetic Viral Controls Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Synthetic Viral Controls Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Synthetic Viral Controls Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Synthetic Viral Controls Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Synthetic Viral Controls Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Synthetic Viral Controls Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Synthetic Viral Controls Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Synthetic Viral Controls Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Synthetic Viral Controls Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Synthetic Viral Controls Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Synthetic Viral Controls Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Synthetic Viral Controls Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Synthetic Viral Controls Market Size by Country (2025-2030) & (US$ Million)
Table 47. Twist Bioscience Company Detail
Table 48. Twist Bioscience Business Overview
Table 49. Twist Bioscience Synthetic Viral Controls Product
Table 50. Twist Bioscience Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 51. Twist Bioscience Recent Development
Table 52. Vector Biolabs Company Detail
Table 53. Vector Biolabs Business Overview
Table 54. Vector Biolabs Synthetic Viral Controls Product
Table 55. Vector Biolabs Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 56. Vector Biolabs Recent Development
Table 57. Premade Lentivirus Particles Company Detail
Table 58. Premade Lentivirus Particles Business Overview
Table 59. Premade Lentivirus Particles Synthetic Viral Controls Product
Table 60. Premade Lentivirus Particles Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 61. Premade Lentivirus Particles Recent Development
Table 62. Telesis Bio Company Detail
Table 63. Telesis Bio Business Overview
Table 64. Telesis Bio Synthetic Viral Controls Product
Table 65. Telesis Bio Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 66. Telesis Bio Recent Development
Table 67. Thermo Fisher Scientific Company Detail
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific Synthetic Viral Controls Product
Table 70. Thermo Fisher Scientific Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 71. Thermo Fisher Scientific Recent Development
Table 72. Sigma Aldrich Company Detail
Table 73. Sigma Aldrich Business Overview
Table 74. Sigma Aldrich Synthetic Viral Controls Product
Table 75. Sigma Aldrich Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 76. Sigma Aldrich Recent Development
Table 77. Antibody Engineering Company Detail
Table 78. Antibody Engineering Business Overview
Table 79. Antibody Engineering Synthetic Viral Controls Product
Table 80. Antibody Engineering Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 81. Antibody Engineering Recent Development
Table 82. Amyris Company Detail
Table 83. Amyris Business Overview
Table 84. Amyris Synthetic Viral Controls Product
Table 85. Amyris Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 86. Amyris Recent Development
Table 87. Precigen Company Detail
Table 88. Precigen Business Overview
Table 89. Precigen Synthetic Viral Controls Product
Table 90. Precigen Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 91. Precigen Recent Development
Table 92. Ginkgo Bioworks Company Detail
Table 93. Ginkgo Bioworks Business Overview
Table 94. Ginkgo Bioworks Synthetic Viral Controls Product
Table 95. Ginkgo Bioworks Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 96. Ginkgo Bioworks Recent Development
Table 97. Codexis Company Detail
Table 98. Codexis Business Overview
Table 99. Codexis Synthetic Viral Controls Product
Table 100. Codexis Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 101. Codexis Recent Development
Table 102. Impossible Foods Company Detail
Table 103. Impossible Foods Business Overview
Table 104. Impossible Foods Synthetic Viral Controls Product
Table 105. Impossible Foods Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 106. Impossible Foods Recent Development
Table 107. National Resilience Company Detail
Table 108. National Resilience Business Overview
Table 109. National Resilience Synthetic Viral Controls Product
Table 110. National Resilience Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 111. National Resilience Recent Development
Table 112. ElevateBio Company Detail
Table 113. ElevateBio Business Overview
Table 114. ElevateBio Synthetic Viral Controls Product
Table 115. ElevateBio Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 116. ElevateBio Recent Development
Table 117. Insitro Company Detail
Table 118. Insitro Business Overview
Table 119. Insitro Synthetic Viral Controls Product
Table 120. Insitro Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 121. Insitro Recent Development
Table 122. Apeel Sciences Company Detail
Table 123. Apeel Sciences Business Overview
Table 124. Apeel Sciences Synthetic Viral Controls Product
Table 125. Apeel Sciences Revenue in Synthetic Viral Controls Business (2019-2024) & (US$ Million)
Table 126. Apeel Sciences Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Synthetic Viral Controls Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Synthetic Viral Controls Market Share by Type: 2023 VS 2030
Figure 3. Monkeypox Controls Features
Figure 4. SARS-COV-2 CONTROLS Features
Figure 5. Respiratory Virus Controls Features
Figure 6. Global Synthetic Viral Controls Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Synthetic Viral Controls Market Share by Application: 2023 VS 2030
Figure 8. Child Case Studies
Figure 9. Teenager Case Studies
Figure 10. Youth Case Studies
Figure 11. Middle-Aged Case Studies
Figure 12. Elder Case Studies
Figure 13. Others Case Studies
Figure 14. Synthetic Viral Controls Report Years Considered
Figure 15. Global Synthetic Viral Controls Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Synthetic Viral Controls Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Synthetic Viral Controls Market Share by Region: 2023 VS 2030
Figure 18. Global Synthetic Viral Controls Market Share by Players in 2023
Figure 19. Global Top Synthetic Viral Controls Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Viral Controls as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Synthetic Viral Controls Revenue in 2023
Figure 21. North America Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Synthetic Viral Controls Market Share by Country (2019-2030)
Figure 23. United States Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Synthetic Viral Controls Market Share by Country (2019-2030)
Figure 27. Germany Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Synthetic Viral Controls Market Share by Region (2019-2030)
Figure 35. China Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Synthetic Viral Controls Market Share by Country (2019-2030)
Figure 43. Mexico Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Synthetic Viral Controls Market Share by Country (2019-2030)
Figure 47. Turkey Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Synthetic Viral Controls Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Twist Bioscience Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 50. Vector Biolabs Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 51. Premade Lentivirus Particles Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 52. Telesis Bio Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 54. Sigma Aldrich Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 55. Antibody Engineering Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 56. Amyris Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 57. Precigen Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 58. Ginkgo Bioworks Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 59. Codexis Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 60. Impossible Foods Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 61. National Resilience Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 62. ElevateBio Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 63. Insitro Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 64. Apeel Sciences Revenue Growth Rate in Synthetic Viral Controls Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
